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This paper deals with the scientometric analysis of the scholarly literature on Convalescent 
Plasma Therapy, or simply Plasma Therapy, as indexed in the SCOPUS database from its first 
publication to 2020. In this study, 1,722 bibliographic records were analysed which are 
published in 545 journals by 9491 authors from 6046 organizations located in nearly 175 
countries. The results showed a sudden increase in the number of publications in 2020 because 
of the clinical trials due to the COVID-19 pandemic. During the period an inconsistent trend 
of publications and the annual growth rate is observed. The average Degree of Collaboration 
calculated for the overall period was 0.89 and Collaboration Index was 6.83. Pediatric 
Nephrology and Transfusion were the most preferred journals; Chantal Loirat was the most 
productive author in the field. The AP-HP Assistance Publique - Hopitaux de Paris, France, 
was the top productive institution and the USA was the most productive country in terms of the 
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The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has created a 
threat to the health and life of people across the globe. It infects majorly the respiratory tract in 
humans and leads to COVID-19 (Coronavirus Disease 2019). According to WHO Coronavirus 
(COVID-19) Dashboard (2021) (as on 27th April 2021) globally there were 14,75,39,302 
confirmed cases of COVID-19 including 31,16,444 deaths were reported. Although 
vaccinations developed by scientists help humans to neutralise antibodies to fight against the 
virus but these vaccines take some time to neutralise antibodies and generate immunity that 
controls the virus infection. Hence the vaccine will help us prevent the spread of COVID-19. 
Even the antiviral drugs failed to bring down the death rates. At this point, there is no definite 
treatment proven to be effective for COVID-19 (as on 30th April, 2021). Hence, the whole 
world is looking for the better treatment options. Many doctors and healthcare researchers are 
testing convalescent plasma therapy or plasma therapy as a ray of hope in patients who are in 
critical situation failed to improve despite the treatment from viral infection (Ray et al., 2020). 
 
 Convalescent plasma therapy or plasma therapy is in use since 1900 to treat emerging 
inflectional diseases (Focosi et al., 2020). Convalescent plasma therapy used to treat patients 
with infections using plasma or specific, fractioned antibodies along with other 
immunoglobulins and possibly healing factors obtained from immunised blood donors 
(Garraud et al., 2016). Plasma therapy is one of the best available options to treat COVID-19 
infection, as convalescent plasma has previously been safe and clinically beneficial for treating 
outbreaks of Ebola, influenza, MERS and SARS coronaviruses (Bakhtawar et al., 2020).  
 
Hence, the current study provides a scientometric mapping of world scholarly literature 
published on the convalescent plasma therapy or plasma therapy research. With the help of 
various scientometric indicators and bibliometric network mapping this study attempts to help 
the researchers, scientists, and medical practitioners understand the research evolution, 





There are ample studies done on plasma therapy and its allied subjects. Şenel et al. 
(2019) conducted a scientometric analysis of medicinal leech therapy using 834 bibliographic 
records as indexed in the Web of Science database published between 1975 and 2017. During 
the study, the highest literature was published in the year 2011. The USA had published the 
maximum i.e. 280 documents, followed by UK (128) and Germany (101). The highest i.e. 22 
scholarly articles published in the journal Microsurgery and the highest i.e. 438 articles 
published under Zoology subject area. I.P. Baskova from the Lomonosov Moscow State 
University was the most productive author, and Lomonosov Moscow State University was the 
most productive institute. In another study Johnson et al. (2020) identified the top 100 most 
cited articles on Covid-19 as indexed in Scopus and Web of Science database. These top-100 
articles were published in more than 50 journals and authors from more than 25 countries. An 
article published in The Lancet has received the highest, i.e. 1185 citations, and X. Li has 
authored 55 publications. Zhongnan Hospital of Wuhan University was a highly contributed 
institution, and China was a highly contributed country. The Lancet was the most preferred 




Mbogning et al. (2020) conducted a bibliometric study to understand the global research 
trend in treating the new Coronavirus disease (COVID-19). The authors analysed 1569 research 
publications indexed in Web of Science published between January 1, 2020 and May 20, 2020. 
The Journal of Medical Virology has posted the highest i.e. 40 research articles. The authors 
contributed these articles from eighty-four countries, and the USA found to be the most 
productive country with 407 publications. Out of 7,374 authors, 17 authors have published 
more than five research articles and the listed in top - 20 highly influential literature in the field. 
Platero-Portillo et al. (2020) published a literature review paper on Convalescent Plasma 
Therapy for COVID-19 Patients. The authors selected 150 papers from Google Scholar and 
PubMed databases, published between November 2019 and July 2020, and shortlisted and 
reviewed 37 articles. 37 articles included 5 case reports, 4 case series, two systematic reviews, 
and 7 article reviews. 
 
Shettar and Hadagali (2020) conducted a scientometric study to analyse the world 
literature publications on Coronavirus. The study collected scholarly articles indexed in the 
Scopus database till 2019. The author analysed 18,116 bibliographic data and found that the 
year 2004 was the most productive year with the highest i.e. 1096 publications and publications 
of 2003 received the highest i.e. 41,351 citations. The Degree of Collaboration for the whole 
period was 0.87 and the Collaborative Co-efficient was 0.60. Collaboration Index was 
calculated to 4.11 and observed a trend towards the multi-authorship. Out of 2,562 journals the 
Journal of Virology was the most preferred journal. Luis Enjuanes of CNB, CSIC, Spain, was 
the leading author with the highest 182 scholarly articles. The University of Hong Kong was 
the leading institution with 511 affiliated research article, and the USA was the most 
contributing country with the highest 5655 publications. 
 
Kodonas et al. (2021) conducted a scientometric study on vital pulp therapy studies 
using research papers indexed on WoS and Scopus database published till 2020. The year 2017 
was the most productive year. Asgary S. of Shahid Beheshti University Medical Sciences, Iran, 
has authored 37 research publications. The USA has the highest contributed country with 194 
publications out of a total 64 countries contributed. Journal of Endodontics was the most 
preferred journal amongst the researchers, and 'Pulpotomy' was the most frequently used 
keyword. Hadagali et al. (2021) published a scientometric analysis of global literature on 
hydroxychloroquine. The study analysed 25,163 publication records as indexed in Scopus 
database till 2020. The study found that 2020 has been the most productive year as initially 
hydroxychloroquine was considered as a prospective drug to cure Covid-19. The authors 
observed that the Compound Annual Growth Rate was 0.129635 and the Relative Growth Rate 
was recorded between 0.04 and 0.56. The average Degree of Collaboration calculated was 0.88 
and Collaboration Index was 5.27. The Journal of Rheumatology was the most preferred 
journal and Didier A. Raoult was the most productive author among 88,834 authors. The AP-
HP Assistance Publique-Hopitaux de Paris, France was a highly productive institute and the 
USA was the most productive country among the 159 contributed scholarly literature on 
hydroxychloroquine.  
 
Zhou and Wang (2021) conducted a scientometric analysis on Human Gener Therapy 
using 62,961 bibliographic records indexed in Scopus, WoS Databases and 42,120 patent 
records from Derewent Innovation databases published between 1996 and 2020. The highest 
number of patents filed were in 2004 (2487) and the highest number of academic publications 
were recorded in 2005 (4793). The USA has recorded the highest i.e. 5598 of scholarly output, 
followed by China (3510) and the UK (1356). Among the institutions, Harvard University has 
the highest (447) academic publications affiliated, followed by INSERM (444) and University 
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College of London (409). James M. Wilson of the University of Pennsylvania has the highest 
(64) publications and Luigi M. Naldini of Vita-Salute San Raffaele University has the highest 
citation counts. It is evident from the above literature reviews that no single bibliometric or 
scientometrics study is conducted till date on research publications in the field of Convalescent 
Plasma Therapy. Hence this study is conducted to help the research community who are 




OBJECTIVES OF THE STUDY 
 
The main objective of this study is to identify and analyse the scholarly literature in the 
field of Convalescent Plasma Therapy indexed in the Scopus database up to 2020. The specific 
objectives are to: 
 
1. study the publications pattern and citation patterns in the world literature on 
Convalescent Plasma Therapy; 
2. determine the Annual Growth Rate (AGR), Relative Growth Rate (RGR) and Doubling 
Time (Dt.) of Convalescent Plasma Therapy; 
3. analyse the Degree of Collaboration (DC), Collaborative Coefficient (CC) and 
Collaboration Index (CI); 
4. study the top twenty-five most preferred journals, productive authors, institutions and 
countries; and 
5. identify the top five highly cited papers among the scholarly literature published on 




MATERIALS AND METHODS 
 
This study is based on the world scholarly literature on Convalescent Plasma Therapy 
retrieved from the Scopus database indexed till 2020. The search string used to retrieve the data 
is as follows: "TITLE-ABS-KEY ("Convalescent plasma" OR "Convalescent plasma therapy" 
OR "Plasma therapy" OR "Plasma-therapy" OR "PlasmaTherapy" OR "Plasma Therapy" OR 
"Plasmatherapy") AND (EXCLUDE (PUBYEAR,2021)))". A total of 1,722 bibliographic 
records were retrieved from the Scopus database in the CSV (comma-separated values) file 
format and further analysed using MS-Excel. Various science mapping and visualisation tools 
were used along with various mathematical formulae to compute the multiple indicators 




ANALYSIS AND INTERPRETATION OF DATA 
 
Year-wise distribution of publications 
 
The table 1 shows the year-wise distribution of publications on Convalescent Plasma 
Therapy research. According to the Scopus database the first research publication on Plasma 
Therapy was indexed in the year 1944. Hence between 1944 and 2020, a total of 1722 research 
papers were published and received 37,619 citations. The highest number of research 
5 
 
publications on Convalescent Plasma Therapy was recorded in the year 2020, i.e. 939, followed 
by 61 in 2019 and 60 in 2016.  
 
 Publications of the year 2020 have received the highest number of citations, i.e. 14,904 
citations, followed by 1989 citations for the publications of the year 2010 and 1602 citations 
for the publications of the year 2011. During the period, fourteen years with minimum one 
publication each have not recorded a single citation. The highest ACPP i.e. 162.4 was recorded 
in the year 1986, followed by 83.43 (2006) and 81.79 (2005). The figure 1 shows the graphical 
representation of year-wise publications and the number of citations received for the research 
publications on Convalescent Plasma Therapy during the study. 
 
Table 1: Year wise distribution of publications 
 
Year TP TC ACPP Year TP TC ACPP 
1944 1 11 11.00 1983 1 52 52.00 
1945 0 0 0.00 1984 8 175 21.88 
1946 0 0 0.00 1985 6 136 22.67 
1947 1 49 49.00 1986 5 812 162.40 
1948 1 0 0.00 1987 6 203 33.83 
1949 1 0 0.00 1988 7 88 12.57 
1950 2 0 0.00 1989 10 228 22.80 
1951 2 0 0.00 1990 7 214 30.57 
1952 1 0 0.00 1991 4 106 26.50 
1953 3 0 0.00 1992 11 364 33.09 
1954 3 0 0.00 1993 5 116 23.20 
1955 1 0 0.00 1994 6 239 39.83 
1956 2 0 0.00 1995 3 62 20.67 
1957 1 9 9.00 1996 9 158 17.56 
1958 1 0 0.00 1997 3 139 46.33 
1959 7 6 0.86 1998 6 114 19.00 
1960 1 0 0.00 1999 4 229 57.25 
1961 2 1 0.50 2000 6 165 27.50 
1962 2 32 16.00 2001 9 523 58.11 
1963 1 0 0.00 2002 13 247 19.00 
1964 2 75 37.50 2003 12 377 31.42 
1965 2 10 5.00 2004 15 473 31.53 
1966 2 7 3.50 2005 14 1145 81.79 
1967 2 14 7.00 2006 14 1168 83.43 
1968 1 4 4.00 2007 16 761 47.56 
1969 1 1 1.00 2008 11 536 48.73 
1970 2 36 18.00 2009 19 1041 54.79 
1971 0 0 0.00 2010 35 1989 56.83 
1972 2 34 17.00 2011 33 1602 48.55 
1973 2 9 4.50 2012 39 1225 31.41 
1974 3 1 0.33 2013 44 1559 35.43 
1975 4 137 34.25 2014 54 1007 18.65 
1976 1 0 0.00 2015 52 1534 29.50 
1977 0 0 0.00 2016 60 1386 23.10 
1978 0 0 0.00 2017 48 867 18.06 
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1979 6 55 9.17 2018 50 675 13.50 
1980 4 31 7.75 2019 61 414 6.79 
1981 4 0 0.00 2020 939 14904 15.87 
1982 6 64 10.67 Total 1722 37619 21.85 
(TP: Total Publications; TC=Total Citations; ACPP: Average Citation per Publication) 
 
 
Figure 1: Annual growth rate of publications and citations  
(TP: Total Publications; TC=Total Citations) 
 
 
Annual Growth Rate (AGR) of publications 
 
The table 2 presents the Annual Growth Rate (AGR) and Compound Annual Growth 
Rate (CAGR). The Annual Growth Rate (AGR) iss calculated on the formula given by Gracio 
et al. (2013). AGR is a simple and standard for measuring the growth in a particular year using 
only two parameters, i.e. First Value and End Value. According to Choi et al. (2011), the 
Growth rate is measured with the Compound Annual Growth Rate (CAGR). CAGR is a 
standard for measuring the growth for the overall period of study. A fluctuating trend was 
observed for AGR during the study period. The highest AGR, i.e. 1439.34 was recorded for 
2020, followed by 700 in 1984 and 600 in 1959. While the minimum AGR was recorded, i.e. 
-100, for three years. The Compound Annual Growth Rate (CAGR) for the total period has 
arrived at 0.094243615. The AGR recorded in 2020 was mainly due to the COVID-19 
pandemic, as clinical trials on Plasma Therapy to cure the coronavirus infection has increased 
drastically. Many researchers published their research in 2020. 
 
Table 2: Annual Growth Rate (AGR) of publications 
 
Year TP AGR Year TP AGR 
1944 1 0 1983 1 -83.33 
1945 0 -100 1984 8 700 
1946 0 0 1985 6 -25 
1947 1 0 1986 5 -16.67 
1948 1 0 1987 6 20 






































































































1950 2 100 1989 10 42.86 
1951 2 0 1990 7 -30 
1952 1 -50 1991 4 -42.86 
1953 3 200 1992 11 175 
1954 3 0 1993 5 -54.55 
1955 1 -66.67 1994 6 20 
1956 2 100 1995 3 -50 
1957 1 -50 1996 9 200 
1958 1 0 1997 3 -66.67 
1959 7 600 1998 6 100 
1960 1 -85.71 1999 4 -33.33 
1961 2 100 2000 6 50 
1962 2 0 2001 9 50 
1963 1 -50 2002 13 44.44 
1964 2 100 2003 12 -7.69 
1965 2 0 2004 15 25 
1966 2 0 2005 14 -6.67 
1967 2 0 2006 14 0 
1968 1 -50 2007 16 14.29 
1969 1 0 2008 11 -31.25 
1970 2 100 2009 19 72.73 
1971 0 -100 2010 35 84.21 
1972 2 0 2011 33 -5.71 
1973 2 0 2012 39 18.18 
1974 3 50 2013 44 12.82 
1975 4 33.33 2014 54 22.73 
1976 1 -75 2015 52 -3.7037 
1977 0 -100 2016 60 15.38 
1978 0 0 2017 48 -20 
1979 6 0 2018 50 4.167 
1980 4 -33.33 2019 61 22 
1981 4 0 2020 939 1439.34 
1982 6 50 CAGR 0.094243615 
 





Relative Growth Rate (RGR) and Doubling Time (Dt.) of publications 
 
The Relative Growth Rate (RGR) is the most practical and widely used growth analysis 
index, introduced to describe the initial phase of growth of annual crops in the field of Botany 
(Blackman, 1919; Hunt, 1982). RGR expresses the change in terms of a rate of increase in 
size per unit of size i.e. the increase in the number of research publications per unit of time, i.e. 
per year. The Doubling time can be calculated by dividing the natural logarithm of 2 by the 
RGR calculated for the time period. It was first adopted by Mahapatra (1985) to calculate the 
doubling time of publications for specific period of interval. The table 3 indicates the Relative 
Growth Rate and Doubling Time of the total research output for Convalescent Plasma Therapy 
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research publications. The Relative Growth Rate of research output has increased from 0.0 to 
0.79 and the mean Relative Growth Rate for the whole study period was 0.097. The fluctuating 
trend was observed throughout the study period. At the same time, the values of Doubling Time 
(Dt.) decreased from 0.99 in 1947 to 0.88 in 2020. The highest i.e. 53.71 Dt. was recorded in 
1983, followed by 39.15 in 1976, and the lowest 0.88 Dt recorded in the year 2020, followed 
by 0.99 in 1947. It is evident from the study that the research in the field of Convalescent 
Plasma Therapy increased in 2020 drastically. 
 
Table 3: Relative Growth Rate (RGR) and Doubling Time (Dt.) of publications 
 
Year TP CTP W1 W2 RGR Dt Year TP CTP W1 W2 RGR Dt 
1944 1 1 0.00 0.00 0.00 0.00 1983 1 78 4.34 4.36 0.01 53.71 
1945 0 1 0.00 0.00 0.00 0.00 1984 8 86 4.36 4.45 0.10 7.10 
1946 0 1 0.00 0.00 0.00 0.00 1985 6 92 4.45 4.52 0.07 10.28 
1947 1 2 0.00 0.69 0.69 1.00 1986 5 97 4.52 4.57 0.05 13.09 
1948 1 3 0.69 1.10 0.41 1.71 1987 6 103 4.57 4.63 0.06 11.55 
1949 1 4 1.10 1.39 0.29 2.41 1988 7 110 4.63 4.70 0.07 10.54 
1950 2 6 1.39 1.79 0.41 1.71 1989 10 120 4.70 4.79 0.09 7.96 
1951 2 8 1.79 2.08 0.29 2.41 1990 7 127 4.79 4.84 0.06 12.22 
1952 1 9 2.08 2.20 0.12 5.88 1991 4 131 4.84 4.88 0.03 22.35 
1953 3 12 2.20 2.48 0.29 2.41 1992 11 142 4.88 4.96 0.08 8.59 
1954 3 15 2.48 2.71 0.22 3.11 1993 5 147 4.96 4.99 0.03 20.03 
1955 1 16 2.71 2.77 0.06 10.74 1994 6 153 4.99 5.03 0.04 17.32 
1956 2 18 2.77 2.89 0.12 5.88 1995 3 156 5.03 5.05 0.02 35.69 
1957 1 19 2.89 2.94 0.05 12.82 1996 9 165 5.05 5.11 0.06 12.36 
1958 1 20 2.94 3.00 0.05 13.51 1997 3 168 5.11 5.12 0.02 38.46 
1959 7 27 3.00 3.30 0.30 2.31 1998 6 174 5.12 5.16 0.04 19.75 
1960 1 28 3.30 3.33 0.04 19.06 1999 4 178 5.16 5.18 0.02 30.49 
1961 2 30 3.33 3.40 0.07 10.04 2000 6 184 5.18 5.21 0.03 20.90 
1962 2 32 3.40 3.47 0.06 10.74 2001 9 193 5.21 5.26 0.05 14.51 
1963 1 33 3.47 3.50 0.03 22.52 2002 13 206 5.26 5.33 0.07 10.63 
1964 2 35 3.50 3.56 0.06 11.78 2003 12 218 5.33 5.38 0.06 12.24 
1965 2 37 3.56 3.61 0.06 12.47 2004 15 233 5.38 5.45 0.07 10.41 
1966 2 39 3.61 3.66 0.05 13.16 2005 14 247 5.45 5.51 0.06 11.88 
1967 2 41 3.66 3.71 0.05 13.86 2006 14 261 5.51 5.56 0.06 12.57 
1968 1 42 3.71 3.74 0.02 28.76 2007 16 277 5.56 5.62 0.06 11.65 
1969 1 43 3.74 3.76 0.02 29.45 2008 11 288 5.62 5.66 0.04 17.80 
1970 2 45 3.76 3.81 0.05 15.24 2009 19 307 5.66 5.73 0.06 10.85 
1971 0 45 3.81 3.81 0.00 0.00 2010 35 342 5.73 5.83 0.11 6.42 
1972 2 47 3.81 3.85 0.04 15.94 2011 33 375 5.83 5.93 0.09 7.52 
1973 2 49 3.85 3.89 0.04 16.63 2012 39 414 5.93 6.03 0.10 7.00 
1974 3 52 3.89 3.95 0.06 11.66 2013 44 458 6.03 6.13 0.10 6.86 
1975 4 56 3.95 4.03 0.07 9.35 2014 54 512 6.13 6.24 0.11 6.22 
1976 1 57 4.03 4.04 0.02 39.15 2015 52 564 6.24 6.34 0.10 7.16 
1977 0 57 4.04 4.04 0.00 0.00 2016 60 624 6.34 6.44 0.10 6.85 
1978 0 57 4.04 4.04 0.00 0.00 2017 48 672 6.44 6.51 0.07 9.35 
1979 6 63 4.04 4.14 0.10 6.92 2018 50 722 6.51 6.58 0.07 9.66 
1980 4 67 4.14 4.20 0.06 11.26 2019 61 783 6.58 6.66 0.08 8.54 
1981 4 71 4.20 4.26 0.06 11.95 2020 939 1722 6.66 7.45 0.79 0.88 
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1982 6 77 4.26 4.34 0.08 8.54        




Figure 2: Year-wise Relative Growth Rate and Doubling Time  
(RGR=Relative Growth Rate; Dt.=Doubling Time) 
 
Degree of Collaboration (D.C.) 
 
The Degree of Collaboration in research can be measured with the help of multi-
authored papers and total publications using the formula derived by Subramanyam (1983). 
According to the table 4, the mean Degree of Collaboration of Convalescent Plasma Therapy 
literature for the period between 1944 and 2020 was 0.89. However, it is observed that the 
Degree of Collaboration increased from 1951-1960 to 2011-2020. The highest i.e. 0.90 Degree 
of Collaboration was recorded for the periods 2001-10 and 2011-20, followed by 0.83 for the 
periods 1981-90 and up to 1950, and the lowest i.e. 0.57 Degree of Collaboration was recorded 
for the period 1951-60, followed by 0.68 during the period 1971-80. 
 


















1950 0 0.00 1 0.51 5 0.33 6 0.83 
1951-60 1 5.88 9 4.62 12 0.79 21 0.57 
1961-70 0 0.00 4 2.05 13 0.86 17 0.76 
1971-80 0 0.00 7 3.59 15 0.99 22 0.68 
1981-90 0 0.00 10 5.13 50 3.31 60 0.83 
1991-2000 0 0.00 11 5.64 46 3.05 57 0.81 
2001-10 3 17.65 16 8.21 139 9.21 155 0.90 
2011-20 13 76.47 137 70.26 1230 81.46 1367 0.90 






















Collaborative Coefficient (CC) and Collaboration Index (CI) 
 
The table 5 shows that the number of multi-authored publications (87.63%) dominates 
over the single-authored publications (11.324%) and few research papers with anonymous 
authors (0.99%). According to the table, out of 1722 research publications on Convalescent 
Plasma Therapy leading 49.71% research publications authored by five or more authors, 
followed by 13.88% papers by three-authors and 13.18% papers by two authors.  
 
The maximum contribution to the literature by multi-authored indicates the 
collaborative trends in the research literature on Convalescent Plasma Therapy. The 
Collaboration Coefficient (CC) as defined by Ajiferuke et al. (1988) lies between 0 and 1, 
where 0 corresponds to single-authored papers and towards collaborative papers. The 
Collaboration Coefficient during the study ranges between 0 and 0.80, with overall CC of 0.65 
during the study. The Collaboration Index (CI) proposed by Lawani (1980) provides the mean 
number of authors per paper for the time period of the study, considering the total number of 
authors and the total number of research publications. The highest i.e. 13.19 CI was recorded 
in 2015, followed by 8.3 (2019) and 7.71 (2020) and the lowest i.e. 0.67 recorded in 1954. The 
Collaboration Index calculated was 6.83, the average number of authors per paper during the 
whole study period. 
 


























1944 0 0 0 1 0 0 1 0.67 3 3.00 
1947 0 0 0 0 0 1 1 0.80 6 6.00 
1948 0 0 1 0 0 0 1 0.50 2 2.00 
1949 0 0 1 0 0 0 1 0.50 2 2.00 
1950 0 1 0 0 1 0 2 0.38 4 2.50 
1951 0 1 0 0 1 0 2 0.38 4 2.50 
1952 0 0 1 0 0 0 1 0.50 2 2.00 
1953 0 0 1 2 0 0 3 0.61 8 2.67 
1954 1 2 0 0 0 0 3 0.33 0 0.67 
1955 0 1 0 0 0 0 1 0.00 0 1.00 
1956 0 1 1 0 0 0 2 0.25 2 1.50 
1957 0 0 0 1 0 0 1 0.67 3 3.00 
1958 0 0 1 0 0 0 1 0.50 2 2.00 
1959 0 4 2 0 0 1 7 0.26 11 2.14 
1960 0 0 1 0 0 0 1 0.50 2 2.00 
1961 0 0 2 0 0 0 2 0.50 4 2.00 
1962 0 1 0 0 0 1 2 0.40 7 4.00 
1963 0 0 0 1 0 0 1 0.67 3 3.00 
1964 0 0 1 1 0 0 2 0.58 5 2.50 
1965 0 1 1 0 0 0 2 0.25 2 1.50 
1966 0 0 0 1 0 1 2 0.73 9 4.50 
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1967 0 1 0 0 1 0 2 0.38 4 2.50 
1968 0 1 0 0 0 0 1 0.00 0 1.00 
1969 0 0 0 0 1 0 1 0.75 4 4.00 
1970 0 0 2 0 0 0 2 0.50 4 2.00 
1972 0 1 0 0 1 0 2 0.38 4 2.50 
1973 0 2 0 0 0 0 2 0.00 0 1.00 
1974 0 1 0 1 1 0 3 0.47 7 2.67 
1975 0 2 0 1 0 1 4 0.37 9 2.75 
1976 0 0 0 0 1 0 1 0.75 4 4.00 
1979 0 0 1 2 1 2 6 0.70 24 4.00 
1980 0 1 0 0 0 3 4 0.60 21 5.50 
1981 0 2 1 1 0 0 4 0.29 5 1.75 
1982 0 2 1 1 0 2 6 0.46 19 3.50 
1983 0 1 0 0 0 0 1 0.00 0 1.00 
1984 0 1 2 3 2 0 8 0.56 21 2.75 
1985 0 1 1 2 1 1 6 0.56 18 3.17 
1986 0 0 1 1 0 3 5 0.71 25 5.00 
1987 0 1 1 2 0 2 6 0.57 18 3.17 
1988 0 1 0 1 2 3 7 0.65 27 4.00 
1989 0 0 1 3 1 5 10 0.73 44 4.40 
1990 0 1 1 1 2 2 7 0.61 25 3.71 
1991 0 2 0 1 0 1 4 0.37 10 3.00 
1992 0 0 1 0 1 9 11 0.77 59 5.36 
1993 0 1 0 0 0 4 5 0.64 23 4.80 
1994 0 2 0 1 0 3 6 0.51 23 4.17 
1995 0 0 0 0 0 3 3 0.80 16 5.33 
1996 0 2 1 1 1 4 9 0.57 39 4.56 
1997 0 0 0 1 1 1 3 0.74 18 6.00 
1998 0 3 2 0 0 1 6 0.30 13 2.67 
1999 0 0 0 1 1 2 4 0.75 19 4.75 
2000 0 1 1 1 0 3 6 0.59 22 3.83 
2001 0 0 1 3 1 4 9 0.72 39 4.33 
2002 1 0 1 3 1 7 13 0.76 63 4.85 
2003 0 1 1 1 4 5 12 0.68 64 5.42 
2004 0 1 1 1 3 9 15 0.71 80 5.40 
2005 0 1 2 0 1 10 14 0.70 94 6.79 
2006 0 3 3 3 2 3 14 0.53 41 3.14 
2007 0 0 2 4 3 7 16 0.72 86 5.38 
2008 0 1 2 3 0 5 11 0.64 50 4.64 
2009 1 5 0 2 1 10 19 0.58 101 5.58 
2010 1 4 3 7 6 14 35 0.65 178 5.20 
2011 1 2 8 3 5 14 33 0.67 157 4.82 
2012 0 4 7 8 3 17 39 0.63 181 4.74 
2013 1 2 7 5 2 27 44 0.70 277 6.34 
2014 2 8 7 7 5 25 54 0.63 247 4.72 
2015 1 2 6 8 4 31 52 0.71 684 13.19 
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2016 0 10 7 7 2 34 60 0.61 361 6.18 
2017 0 4 4 12 3 25 48 0.67 254 5.38 
2018 0 1 4 7 5 33 50 0.74 371 7.44 
2019 0 4 9 7 13 28 61 0.68 502 8.30 
2020 8 100 122 116 104 489 939 0.66 7138 7.71 
Total 17 195 227 239 188 856 1722 0.65 11574 6.83 
% 0.99 11.32 13.18 13.88 10.92 49.71 100    
(CC: Collaborative Coefficient and CI: Collaboration Index) 
 
Top ten most preferred journals in the Plasma Therapy Research 
 
The table 6 presents the top-10 most preferred journals from the 545 journals by the 
authors in Convalescent Plasma Therapy. Pediatric Nephrology, a journal published by 
Pediatric Nephrology and Transfusion, a journal published by Wiley-Blackwell were the most 
preferred journals with 34 research publications each on Plasma Therapy, followed by 
Transfusion and Apheresis Science with 32 research papers. Among the top-10 most preferred 
journals, the JAMA Journal of the American Medical Association has received the highest i.e. 
2093 citations from 14 research publications, followed by Pediatric Nephrology with 1457 
citations from 34 publications; New England Journal of Medicine has received 1314 citations 
from the 17 research papers.  
 
New England Journal of Medicine, the journal published by Massachusetts Medical 
Society has the highest Impact Factor of 74.699 amongst the top-10 most preferred journals in 
the field of 'Plasma Therapy' research, followed by JAMA Journal of the American Medical 
Association (IF 45.54) and Blood (IF 17.543). Wiley-Blackwell has published two journals 
among the top-10 most preferred journals in the field of Convalescent Plasma Therapy. Five 
journals were published from the United States of America, followed by three journals from 
the United Kingdom and one each from Germany and Switzerland. 
 
Table 6: Top ten most preferred journals in the Convalescent Plasma Therapy research 
 
Source Title TP TC IF (2020) Publisher Country 
Pediatric Nephrology 34 1457 2.676 Pediatric Nephrology USA 
Transfusion 34 453 2.8 Wiley-Blackwell  UK 
Transfusion and Apheresis 
Science 32 313 1.285 Elsevier UK 
Blood 18 1304 17.543 
American Society of 
Hematology USA 
New England Journal of 
Medicine 17 1314 74.699 
Massachusetts 
Medical Society USA 
Clinical Plasma Medicine 14 150 NA Elsevier Germany 
JAMA Journal of The 
American Medical 
Association 14 2093 45.54 
American Medical 
Association USA 
Journal of Infectious 
Diseases 14 698 5.022 
Oxford University 
Press UK 
Frontiers in Immunology 12 115 5.085 Frontiers Media S.A. Switzerland 
Journal of Medical Virology 12 963 2.021 Wiley-Blackwell USA 
(TP: Total Publications; TC=Total Citations) 
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Top ten productive authors in the convalescent plasma therapy research 
 
Out of 9491 authors, the table 7 shows the top-10 prolific authors in Convalescent 
Plasma Therapy research with their affiliations and publications patterns. Chantal Loirat of 
Hôpital Robert-Debré AP-HP, Paris and Agnès Veyradier of Université de Paris, Paris were 
leading the table with the highest i.e.19 publications each, followed by Véronique Frémeaux-
Bacchi of Hopital Europeen Georges-Pompidou, Paris with 17 publications. However, 
according to the number of citations received, Chantal Loirat leads the table with the maximum 
i.e.1913 citations, followed by Giuseppe Remuzzi of Istituto di Ricerche Farmacologiche 
Mario Negri, Milan (1145 citations) and Véronique Frémeaux-Bacchi of Hopital Europeen 
Georges-Pompidou, Paris (1124 citations). According to h-index Chantal Loirat with h-index 
16 lead the table, followed by Véronique Frémeaux-Bacchi (15) and Agnès Veyradier (10). 
 
Among the top-10 most prolific authors, two authors belong to Paris Diderot 
University, Paris, and the remaining were from other institutions. However, the top-4 authors 
belong to France and others are from six different countries. The figure 3 presents the 
bibliographic coupling of contributing authors. Authors are divided into 12 clusters of the 
networks between the authors based on their number of collaborations and associations 
between the individual authors. This network map shows highly contributing authors with a 
minimum of 4 publications each, and the network map has 12 clusters of 177 authors with 1218 
links and 1978 link strengths.  
 
Table 7: Top ten productive authors in the convalescent plasma therapy research 
 
Author Name Affiliation Country TP TC h-index 
Loirat, Chantal 
Hôpital Robert-Debré AP-HP, 
Paris  France 19 1913 16 
Veyradier, 





Pompidou, Paris  France 17 1124 15 
Coppo, Paul Inserm, Paris  France 13 375 7 
Casadevall, 
Arturo 
Johns Hopkins Bloomberg 
School of Public Health, 
Baltimore  USA 10 749 9 
Andía, Isabel 
Biocruces Bizkaia Instituto de 
Investigación Sanitaria, 
Baracaldo  Spain 10 385 9 
Licht, Christoph 
P.B. 
Hospital for Sick Children 
University of Toronto, Toronto  Canada 9 698 9 
Remuzzi, 
Giuseppe 
Istituto di Ricerche 
Farmacologiche Mario Negri, 
Milan  Italy 8 1145 7 
Van Griensven, 
Johan 
Prins Leopold Instituut voor 
Tropische Geneeskunde, 
Antwerpen  Belgium 8 514 8 
Roberts, David 
J. John Radcliffe Hospital, Oxford  UK 8 68 4 






Figure 3: Bibliographic coupling of contributing authors 
 
 
Top ten most prolific institutions in the Convalescent Plasma Therapy research 
 
The table 8 lists out the top-10 most prolific institutions out of 6046 contributing 
organizations based on the number of publications in Convalescent Plasma Therapy research. 
Among the top-10 institutes, AP-HP Assistance Publique - Hopitaux de Paris has contributed 
the highest i.e. 36 research papers, followed by the University of Toronto (27) and National 
Institutes of Health NIH & Université de Paris (25 each). The list of institutes based on the 
ranking by the number of citations received was led by AP-HP Assistance Publique - Hopitaux 
de Paris with 2202 citations from 34 research papers, followed by Université de Paris with 
1861 citations from 25 publications and Hopital Europeen Georges-Pompidou with 1846 
citations from 23 research papers. Among the top-10 institutes that contributed the maximum 
number of research papers in Plasma Therapy research, AP-HP Assistance Publique - Hopitaux 
de Paris has received the highest i.e.22 h-index, followed by Hopital Europeen Georges-
Pompidou (20) and Université de Paris (17). 
 
Out of the top ten highly contributed institutions, five institutions are based in Paris 
alone, followed by one in five different cities. Out of these ten institutes, five are based in 
France and two each from the USA and U.K. and one from Canada. The figure 4 shows the 
graphical visualisation of bibliographic coupling of collaborating institutions in the field of 
Convalescent Plasma Therapy research. Out of 6046 contributing institutes, only 47 institutes 
had met the threshold of a minimum of 3 publications to be considered for Bibliographic 
Coupling of Organisations. But out of 47, only ten organisations collaborated with each other. 
Hence, the network map shows only one cluster of 10 institutions, with 45 links and 135 total 





Table 8: Top ten prolific institutions in the convalescent plasma therapy research 
 
Affiliation City Country TP TC 
h-
index 
AP-HP Assistance Publique - Hopitaux de 
Paris Paris France 36 2202 22 
University of Toronto Toronto Canada 27 910 16 
National Institutes of Health NIH Bethesda USA 25 681 12 
Université de Paris Paris France 25 1861 17 
Icahn School of Medicine at Mount Sinai New York USA 24 938 9 
Inserm Paris France 23 932 12 
Hopital Europeen Georges-Pompidou Paris France 23 1846 20 
University of Oxford Oxford UK 22 673 10 
NHS Blood and Transplant Bristol UK 22 393 9 
Hôpital Robert-Debré AP-HP Paris France 20 1914 16 
 
(TP: Total Publications; TC=Total Citations) 
 
 
Figure 4: Bibliographic coupling of collaborating Institutions 
 
 
Top ten most productive countries in the convalescent plasma therapy research 
 
A total of 175 countries contributed to the Convalescent Plasma Therapy research with 
at least one publication. The table 9 list out the top-10 contributing countries based on the 
number of publications. The United States of America was the leading country with 550 
(31.94%) publications, followed by China with 170 (9.87%) and India with 156 (9.06%) 
publications ranked first to third respectively. The USA has also received the highest (14,333) 
citations, followed by China (7080) and the United Kingdom (5585) during the study. 
According to the h-index, the USA lead the table (60), followed by China and France with 32 




The top-10 countries have contributed 1491 (86.59%) publications. Among the top ten 
most contributing countries, developed countries focused on the field of Plasma Therapy 
research. Co-authorship network analysis provides information about collaboration patterns 
between countries. The figure 5 depicts the graphical visualisation on the bibliographic 
coupling of 53 collaborating countries with a minimum of 5 research publications each. This 
network map has 8 clusters of 53 countries, 581 links and 1614 link strengths.  
 
 
Table 9: Top ten most productive countries in the Convalescent Plasma Therapy 
research 
 
Country TP TC 
h-
index 
United States 550 14333 60 
China 170 7080 32 
India 156 1239 18 
United Kingdom 131 5585 33 
Germany 108 2879 27 
France 107 4171 32 
Italy 94 2414 23 
Canada 77 2355 24 
Spain 54 1658 20 
Iran 44 515 11 
(TP: Total Publications; TC=Total Citations) 
 








Keyword co-occurrence analysis 
 
The keyword co-occurrence map (Figure 6) was constructed using VOSviewer 
visualisation software with the help of bibliographic data extracted from the Scopus citation 
database on convalescent plasma therapy research. Keywords co-occurrence networks were 
chosen to identify important keywords used, and this network map is helpful to provide a clear 
understanding of the associated content of the selected articles. The Keyword co-occurrence 
map visualises the terms appeared at least 100 times as keyword in all documents under study, 
which listed the 92 highly used keywords amongst the 10630 keywords used. There are four 
clusters in the above map with 92 keywords; 4043 links and 214311 total link strength. The 
links between two keywords in the network show number of times the keywords linked 
appeared together in the publications. Higher the number of connections between two 
keywords, the higher the number of times they have co-occurred in the documents. It is 
important to highlight that all three clusters have links to each other. The network-based on 
keywords determines the nature of research and research hotspots in the convalescent plasma 
therapy research area. The keywords which are highly used are human, convalescent plasma, 
virus pneumonia etc. Even keywords like coronavirus disease 2019, coronavirus infection, 
covid-19, etc., have prominently placed in these highly used keywords and created a separate 
cluster in red colour, mostly published in 2020. 
 
 
Figure 6: Mapping of Keyword Co-occurrence 
 
Top five most influential articles in the convalescent plasma therapy research 
 
The table 10 depicts the top five highly cited publications in Convalescent Plasma 
Therapy research receiving more than 500 citations. The article titled, "Treatment of 5 
Critically Ill Patients with COVID-19 with Convalescent Plasma" by Shen C. et al. (total 27 
authors) published online on March 27, 2020, in JAMA - Journal of the American Medical 
Association has received the highest 1020 citations in a year, whereas, second highly cited 




Table 10: Top five most influential articles 
 




Treatment of 5 Critically Ill 
Patients with COVID-19 with 
Convalescent Plasma Shen C. et al. 27 
2020, JAMA - Journal of 
the American Medical 
Association, 323(16), pp. 
1582-1589 1020 
Effectiveness of convalescent 
plasma therapy in severe COVID-
19 patients Duan K. et al. 48 
2020, Proceedings of the 
National Academy of 
Sciences of the United 
States of America, 
117(17), pp. 9490-9496 760 
Lassa Fever 
Mccormick J.B. 
et al. 8 
1986, New England 
Journal of Medicine, 
314(1), pp. 20-26 666 
SARS: Systematic review of 
treatment effects 
Stockman L.J., 
Bellamy R. and 
Garner P. 3 
2006, PLoS Medicine, 
3(9), pp. 1525-1531 636 
Relative role of genetic 
complement abnormalities in 
sporadic and familial aHUS and 
their impact on clinical phenotype Noris M. et al. 18 
2010, Clinical Journal of 
the American Society of 
Nephrology, 5(10), pp. 
1844-1859 568 
 
Findings and Conclusion 
 
COVID-19 seems to be the most dangerous virus among the Coronavirus family. There 
is no full-proof treatment method to cure the COVID-19 infection and scientists around the 
world are working on it. Meanwhile, many scientists and researchers are testing the existing 
treatment methods to adopt to control COVID-19. One among them is Convalescent Plasma 
Therapy which used to prevent and control infection for many years. Thousands of researchers 
published their research work on Convalescent Plasma Therapy in journal articles, conference 
papers, book chapters, notes, surveys etc. The present study attempts to analyse the records on 
Convalescent Plasma Therapy from its first indexed article in 1944 to 2020 extracted from the 
Scopus database. 
 
Among the 1,722 scholarly publications retrieved from the Scopus database, 1008 
(58.54%) publications were published as Open Access and received 25,177 (66.93%) citations. 
The maximum publications were published in the year 2020 due to the increase in research and 
clinical trials on Convalescent Plasma Therapy. A fluctuating trend was observed for AGR and 
CAGR and the calculated value was 0.094243615. The study noticed an increased RGR from 
0.0 to 0.79 and decreased doubling time from 0.99 to 0.88. Multi-authored publications trend 
has been observed over the single-authored publications, resulting in a 6.83 Collaborative 
Index with a 0.89 Degree of Collaboration and 0.65 mean Collaboration Coefficient. 
 
Pediatric Nephrology and Transfusion were the highly preferred journals by the authors 
among the 545 journals, and JAMA Journal of the American Medical Association was the most-
cited journal. Chantal Loirat of Hôpital Robert-Debré AP-HP, Paris is a highly published 
scholar in plasma research and AP-HP Assistance Publique - Hopitaux de Paris is a highly 
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affiliated institute among the 6046 organisations. First four highly contributing institutes are 
based in France only. Fifty-three countries collaborated and contributed research papers, and 
the United States of America has contributed the highest publications. 'Human or Humans" are 
the most preferred keywords, followed by 'Coronavirus Disease 2019' in the world literature 
on Convalescent Plasma Therapy. The COVID-19 pandemic has forced scientists, researchers 
and practitioners to undertake quick research and clinical studies, which resulted in the 
multifold increase in the Convalescent Plasma Therapy literature. Hence, this study will help 
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